A catalytically inactive mutant of the deubiquitylase YOD-1 enhances antigen cross-presentation

Blood

Volumn 121, Issue 7, 2013, Pages 1145-1156

  Sehrawat, Sharvan ^a   Koenig, Paul Albert ^a   Kirak, Oktay ^b   Schlieker, Christian ^c   Fankhauser, Manuel ^a   Ploegh, Hidde L ^a  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEUBIQUITYLASE YOD1; ENZYME; OVALBUMIN; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CROSS PRESENTATION; ENDOPLASMIC RETICULUM; GAMMAHERPESVIRINAE; GOLGI COMPLEX; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA VIRUS A; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 84874090275     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-08-447409     Document Type: Article

References (45)

1. Rock KL, Shen L. Cross-presentation: underlying mechanisms and role in immune surveillance. Immunol Rev. 2005;207:166-183. (Pubitemid 41415016)
2. Vyas JM, Van der Veen AG, Ploegh HL. The known unknowns of antigen processing and presentation. Nat Rev Immunol. 2008;8(8):607-618.
3. Salio M, Cella M, Suter M, Lanzavecchia A. Inhibition of dendritic cell maturation by herpes simplex virus. Eur J Immunol. 1999;29(10):3245-3253. (Pubitemid 29484215)
4. Servet-Delprat C, Vidalain PO, Bausinger H, et al. Measles virus induces abnormal differentiation of CD40 ligand-activated human dendritic cells. J Immunol. 2000;164(4):1753-1760. (Pubitemid 30108726)
5. Engelmayer J, Larsson M, Subklewe M, et al. Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J Immunol. 1999;163(12):6762-6768.
6. Bevan MJ. Antigen recognition: class discrimination in the world of immunology. Nature. 1987; 325(6101):192-194.
7. Ahmed R, Bevan MJ, Reiner SL, Fearon DT. The precursors of memory: models and controversies. Nat Rev Immunol. 2009;9(9):662-668.
8. Amigorena S, Savina A. Intracellular mechanisms of antigen cross presentation in dendritic cells. Curr Opin Immunol. 2010;22(1):109-117.
9. Lennon-Dumenil AM, Bakker AH, Maehr R, et al. Analysis of protease activity in live antigen-presenting cells shows regulation of the phago-somal proteolytic contents during dendritic cell activation. J Exp Med. 2002;196(4):529-540.
10. Grant EP, Michalek MT, Goldberg AL, Rock KL. Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class I presentation. J Immunol. 1995;155(8):3750-3758.
11. Germain RN, Robey EA, Cahalan MD. Adecade of imaging cellular motility and interaction dynamics in the immune system. Science. 2012; 336(6089):1676-1681.
12. Kovacsovics-Bankowski M, Rock KLAphagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science. 1995; 267(5195):243-246.
13. Falo LD, Jr., Kovacsovics-Bankowski M, Thompson K, Rock KL. Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity. Nat Med. 1995;1(7):649-653.
14. Ackerman AL, Giodini A, Cresswell P. A role for the endoplasmic reticulum protein retrotransloca-tion machinery during crosspresentation by dendritic cells. Immunity. 2006;25(4):607-617. (Pubitemid 44529035)
15. Smith MH, Ploegh HL, Weissman JS. Road to ruin: targeting proteins for degradation in the endoplasmic reticulum. Science. 2011;334(6059): 1086-1090.
16. Ernst R, Mueller B, Ploegh HL, Schlieker C. The otubain YOD1 is a deubiquitinating enzyme that associates with p97to facilitate protein dislocation from the ER. Mol Cell. 2009;36(1):28-38.
17. Sehrawat S, Kirak O, Koenig PA, et al. CD8(+) T Cells from MiceTransnuclear for aTCR that Recognizes a Single H-2K(b)-Restricted MHV68 Epitope Derived from gB-ORF8 Help Control Infection. Cell Rep. 2012;1(5):461-471.
18. Topham DJ, Castrucci MR, Wingo FS, Belz GT Doherty PC. The role of antigen in the localization of naive, acutely activated, and memory CD8(+) T cells to the lung during influenza pneumonia. J Immunol. 2001;167(12):6983-6990. (Pubitemid 33144193)
19. Neyts J, De Clercq E. In vitro and in vivo inhibition of murine gamma herpesvirus 68 replication by selected antiviral agents. Antimicrob Agents Chemother. 1998;42(1):170-172. (Pubitemid 28053346)
20. Reiley WW, Zhang M, Jin W, et al. Regulation of T-cell development by the deubiquitinating enzyme CYLD. Nat Immunol. 2006;7(4):411-417.
21. Clarke SR, Barnden M, Kurts C, Carbone FR, Miller JF, Heath WR. Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection. Immunol Cell Biol. 2000;78(2):110-117. (Pubitemid 30220105)
22. Iyoda T, Shimoyama S, Liu K, et al. The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J Exp Med. 2002; 195(10):1289-1302. (Pubitemid 34564331)
23. Guermonprez P, Valladeau J, Zitvogel L, Thery C, Amigorena S. Antigen presentation and T-cell stimulation by dendritic cells. Annu Rev Immunol. 2002;20:621-667. (Pubitemid 34293436)
24. Guermonprez P, Saveanu L, Kleijmeer M, Davoust J, Van Endert P, Amigorena S. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature. 2003; 425(6956):397-402. (Pubitemid 37187268)
25. Burgdorf S, Scholz C, Kautz A, Tampe R, Kurts C. Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation. Nat Immunol. 2008;9(5):558-566. (Pubitemid 351560525)
26. Kapuria V, Peterson LF, Fang D, Bornmann WG, Talpaz M, Donato NJ. Deubiquitinase inhibition by small-molecule WP1130 triggers aggresome formation and tumor cell apoptosis. Cancer Res. 2010;70(22):9265-9276.
27. Delamarre L, Pack M, Chang H, Mellman I, Trombetta ES. Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science. 2005;307(5715):1630-1634. (Pubitemid 40354746)
28. Spadaro F, Lapenta C, Donati S, et al. IFN-alpha enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing, and processing. Blood. 2012;119(6): 1407-1417.
29. Chefalo PJ, Harding CV. Processing of exogenous antigens for presentation by class I MHC molecules involves post-Golgi peptide exchange influenced by peptide-MHC complex stability and acidic pH. J Immunol. 2001;167(3):1274-1282. (Pubitemid 32703122)
30. Trombetta ES, Ebersold M, Garrett W, Pypaert M, Mellman I. Activation of lysosomal function during dendritic cell maturation. Science. 2003; 299(5611):1400-1403. (Pubitemid 36254654)
31. Jancic C, Savina A, Wasmeier C, et al. Rab27a regulates phagosomal pH and NADPH oxidase recruitment to dendritic cell phagosomes. Nat Cell Biol. 2007;9(4):367-378. (Pubitemid 46511070)
32. Savina A, Jancic C, Hugues S, et al. NOX2 controls phagosomal pH to regulate antigen processing during cross-presentation by dendritic cells. Cell. 2006;126(1):205-218. (Pubitemid 44026552)
33. Mantegazza AR, Savina A, Vermeulen M, et al. NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells. Blood. 2008;112(12):4712-4722.
34. Cebrian I, Visentin G, Blanchard N, et al. Sec22b regulates phagosomal maturation and antigen cross-presentation by dendritic cells. Cell. 2011; 147(6):1355-1368.
35. Randow F, Munz C. Autophagy in the regulation of pathogen replication and adaptive immunity Trends Immunol. 2012;33(10):475-487.
36. Guimaraes CP, Carette JE, Varadarajan M, et al. Identification of host cell factors required for intoxication through use of modified cholera toxin. J Cell Biol. 2011;195(5):751-764.
37. Carette JE, Guimaraes CP, Varadarajan M, et al. Haploid genetic screens in human cells identify host factors used by pathogens. Science. 2009; 326(5957):1231-1235.
38. Pooley JL, Heath WR, Shortman K. Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8-dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells. J Immunol. 2001;166(9):5327-5330. (Pubitemid 32374150)
39. Reis e Sousa C, Germain RN. Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J Exp Med. 1995;182(3):841-851.
40. Ackerman AL, Cresswell P. Cellular mechanisms governing cross-presentation of exogenous antigens. Nat Immunol. 2004;5(7):678-684. (Pubitemid 39023296)
41. Rock KL. A new foreign policy: MHC class I molecules monitor the outside world. Immunol Today. 1996;17(3):131-137. (Pubitemid 26074502)
42. Kovacsovics-Bankowski M, Clark K, Benacerraf B, Rock KL. Efficient major histocom-patibility complex class I presentation of exogenous antigen upon phagocytosis by macro-phages. Proc Natl Acad Sci USA. 1993;90(11): 4942-4946. (Pubitemid 23182951)
43. Gasteiger G, Kastenmuller W, Ljapoci R, Sutter G, Drexler I. Cross-priming of cytotoxic T cells dictates antigen requisites for modified vaccinia virus Ankara vector vaccines. J Virol. 2007;81(21):11925-11936. (Pubitemid 47623824)
44. Larsson M, Fonteneau JF, Somersan S, et al. Efficiency of cross presentation of vaccinia virus-derived antigens by human dendritic cells. Eur J Immunol. 2001;31(12):3432-3442. (Pubitemid 34030955)
45. Lee BH, Lee MJ, Park S, et al. Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature. 2010;467(7312):179-184.